[Pathogenetic heterogeneity of chronic lympholeukemia and the possibilities for its immunotherapy].
Melekhin
V D
VD
Siniachenko
V V
VV
Andronati
S A
SA
Litvinova
L A
LA
Ostrovskiĭ
K G
KG
D000368:Aged; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D007958:Leukocyte Count / Q000187:drug effects; D007978:Levamisole / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012397:Rosette Formation; D013994:Tilorone / Q000494:pharmacology / Q000627:therapeutic use
D007978:Levamisole; D013994:Tilorone
O patogeneticheskoĭ neodonorodnosti khronicheskogo limfoleĭkoza i vozmozhnostiakh ego immunoterapii.